Market Place
Sourcing Support
All News #Library
Biotech
Daré Bioscience Reports 2025 Financials, Business Update
26 Mar 2026 //
GLOBENEWSWIRE
National Viagra Day: Women Claim Their Turn
23 Mar 2026 //
GLOBENEWSWIRE
Daré Bio to Host 2025 Financial Results Call on March 26
20 Mar 2026 //
GLOBENEWSWIRE
Daré Bio Receives NIH Funding Award Notice to Advance DARE-PTB1
16 Mar 2026 //
GLOBENEWSWIRE
Daré Bioscience Regains Ovaprene Rights, Shares Phase 3 Update
01 Dec 2025 //
GLOBENEWSWIRE
Daré Bioscience Receives $3.6 Million In Additional Grant Funding
24 Nov 2025 //
GLOBENEWSWIRE
Daré Bioscience Prepares For DARE To PLAY Sildenafil Cream
11 Nov 2025 //
GLOBENEWSWIRE
Daré Bio To Host Q3 2025 Financial Results Conference Call
06 Nov 2025 //
GLOBENEWSWIRE
Daré Bio To Get $300K For Contraceptive Innovation Assessment
03 Nov 2025 //
GLOBENEWSWIRE
Daré Bioscience to Host Q2 2025 Financial Results Conference Call
07 Aug 2025 //
GLOBENEWSWIRE
Daré Boosts Interest in Female Sexual Arousal Drug
30 Jul 2025 //
FIERCE PHARMA
Daré Bio`s August 6 Webinar: The DARE to PLAY™ Sildenafil Cream
21 Jul 2025 //
GLOBENEWSWIRE
FDA delays force Daré to shelve phase 3 plans
18 Apr 2025 //
FIERCE BIOTECH
Dare Bioscience to Host Full Year 2024 Financial Results and Call
24 Mar 2025 //
GLOBENEWSWIRE
Daré Bioscience Receives $10M Award from ARPA-H
23 Oct 2024 //
GLOBENEWSWIRE
XOMA Royalty Reports Q2 2024 Results And Recent Activities
13 Aug 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.